Article: Third Wave Signs Agreement With Japan's National Cancer Center For Comprehensive Cancer Genotyping Program.

MADISON, Wis. -- Third Wave Technologies Inc. today announced that Japan's National Cancer Center (NCC) will use Third Wave Invader(R) products to genotype more than 100,000 different genetic variations in each of several hundred individuals in a large-scale study to discover the genetic foundations of cancer. This collaboration further expands Third Wave's leadership in the first-mover Japanese genetic analysis market.

The NCC study is believed to be the largest genomic discovery project ever aimed at understanding cancer. It is one of the cornerstones of Japan's comprehensive cancer program to decrease the incidence of the disease and improve the standard of ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!